| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Nachrichten zu Amgen Inc.
|
31.01.23
|
Amgen Inc. Bottom Line Declines In Q4 (RTTNews)
|
|
31.01.23
|
|
|
31.01.23
|
|
|
26.01.23
|
|
|
04.01.23
|
|
|
13.12.22
|
|
|
13.12.22
|
|
|
12.12.22
|
|
|
12.12.22
|
|
|
12.12.22
|
|
|
01.12.22
|
Form 8.3 - The Vanguard Group, Inc.: Amgen Inc (EQS Group)
|
|
01.12.22
|
|
|
28.11.22
|
AMGEN TO WEBCAST INVESTOR CALL AT WCIRDC 2022 (PR Newswire)
|
|
23.11.22
|
|
|
09.11.22
|
|
|
07.11.22
|
|
|
07.11.22
|
|
|
07.11.22
|
|
|
07.11.22
|
|
|
04.11.22
|
|
|
03.11.22
|
Amgen Inc. Profit Advances In Q3 (RTTNews)
|
|
03.11.22
|
AMGEN REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
|
|
02.11.22
|
AMGEN TO WEBCAST INVESTOR CALL AT AHA 2022 (PR Newswire)
|
|
31.10.22
|
|
|
28.10.22
|
AMGEN ANNOUNCES 2022 FOURTH QUARTER DIVIDEND (PR Newswire)
|
|
20.10.22
|
AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX (PR Newswire)
|
|
12.10.22
|
|
|
06.10.22
|
|
|
12.09.22
|
|
|
12.09.22
|
|
|
12.09.22
|
|
|
12.09.22
|
|
|
08.09.22
|
|
|
08.09.22
|
|
|
08.09.22
|
|
|
07.09.22
|
AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2022 (PR Newswire)
|
|
02.09.22
|
|
|
02.09.22
|
|
|
30.08.22
|
|
|
30.08.22
|
|
|
29.08.22
|
|
|
23.08.22
|
|
|
23.08.22
|
|
|
22.08.22
|
|
|
08.08.22
|
AMGEN PRESENTS NEW TARLATAMAB CLINICAL DATA AT WCLC 2022 (PR Newswire)
|
|
07.08.22
|
|
|
04.08.22
|
|
|
04.08.22
|
AMGEN REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
|
|
04.08.22
|
|
|
04.08.22
|
AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH (PR Newswire)
|